Objectives: We investigated whether the acetylcholine receptor (AChR) cluster cell-based assay (CBA) is effective in detecting AChR antibodies in sera from myasthenia gravis (MG) patients with low ...

Whilst these data suggest the potential for the development of GluN1 antibody therapy, paradoxically GluN1 autoantibodies in humans are associated with the pathogenesis of the autoimmune disease ...

The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

Find more information on the Altmetric Attention Score and how the score is calculated. Antibodies directed against the epidermal growth factor receptor (EGFR) offer a potentially powerful therapeutic ...

On June 16, 2025, RemeGen Co., Ltd. ('RemeGen', stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand ...

The stem portion confers additional functions to antibodies, including fixing complement and activating immune cells by binding to crystallizable fragment (Fc) receptors. Finally, fragment modes ...

Alterations in thyroid gland function result from the action of stimulating or blocking autoantibodies on cell membrane receptors ... a result of a mother with antibodies due to AITD.

Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Korea Radiological and Medico-Oncological Sciences, University of Science and Technology, Seoul 01812, Korea ...

Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth cohorts from the Environmental Influences on Child Health Outcomes Children ...

Zilucoplan (Zilbrysq; UCB) is a once-daily subcutaneous C5 complement inhibitor that has demonstrated long-term treatment benefits in patients who have acetylcholine receptor antibody–positive ...

每年的6月15日是世界重症肌无力日（World Myasthenia Gravis Day）。重症肌无力（MG）是一种全球性的 自身免疫疾病 ...